Sodium nitroprusside is a vasodilatory agent that exerts its effects via the release of nitrous oxide causing a reduction in both preload and afterload ... This drug should be avoided in patients ...

In the present review, we explore the pathophysiology of ARVF, highlighting the different mechanisms that may lead to this clinical entity and emphasizing the left and right heart ... that affect ...

By quantifying the ratio of left atrial to left ventricular end-diastolic volumes, LACI offers unprecedented prognostic insights into a wide range of cardiovascular diseases, including atrial ...

A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin ...

Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered, potentially paving the way for innovative treatments that align with the natural ...

The differences in risk of sudden cardiac death varied by age and how long people took antidepressants, with people taking these medications for longer periods of time being the most at risk.

Sales of the drug totaled $602 million in 2024. ODYSSEY-HCM is a double-blind, placebo-controlled trial that enrolled 580 adult patients and tested the hypothesis of whether a cardiac myosin ...

and a drug group to see if those taking oral semaglutide were more or less likely to experience major cardiac events. Both groups were given standard-of-care glucose-lowering and cardiovascular ...